This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page


    Page   1/1   
  • 2014 Global health care sector outlook
    The report examines the current state of the global health care sector, provides a snapshot of activity in a number of geographic markets, and suggests considerations for stakeholders as they address funding, cost and other issues while seeking to grow revenue and market share in 2014 and beyond.
  • Transformation beyond reform: A changing life sciences & health care industry
    In conjunction with the Financial Times/Deloitte 2013 Health Care & Life Sciences conference, explore what lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform.
  • Health reform and life sciences: Threat, opportunity or both?
    New survey of 295 senior life sciences execs shows enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts on the life sciences industry from health care reforms around the world.
  • Life Sciences: Accounting and Financial Reporting Update
    Publication highlights specialized accounting and reporting considerations applicable to companies in this life sciences industry.
  • Big pharma: Business model choices for the new market
    The pharmaceutical industry faces a critical need for change. Explore ideas as to how pharmaceutical companies can re-orient their business model to deliver value in the new life sciences market.
  • 2013 Global life sciences sector outlook
    New report examines the current state of the global life sciences industry, explores top issues, reviews activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2013 and beyond.
  • Deloitte ranked #1 in life sciences
    Deloitte has been ranked number one in Life Sciences consulting services by Kennedy Information based on revenue. Ranking covers the four subsectors: pharmaceutical, biotechnology, medical device, and drug distribution.
  • Page   1/1   
Material on this website is © 2014 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see “About Deloitte” for a more detailed description of DTTL and its member firms.

Get connected
Share your comments


More on Deloitte
Learn about our site